Effect of Chromium on Glucose and Lipid Profiles in Patients with Type 2 Diabetes; A Meta-analysis Review of Randomized Trials
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Purpose. Chromium (Cr) as an essential trace element in metabolism of carbohydrate, lipid and protein is currently prescribed to control diabetes mellitus (DM). The objective of this meta-analysis was to compare the effect of Cr versus placebo (Pl) on glucose and lipid profiles in patients with type 2 DM. Methods. Literature searches in PubMed, Scopus, Scirus, Google Scholar and IranMedex was made by use of related terms during the period of 2000-2012. Eligible studies were randomized clinical trials (RCTs) with intake of Cr higher than 250 µg at least for three months in type 2 DM. Glycated hemoglobin (HbA1c), fasting blood sugar (FBS), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), very low-density lipoprotein cholesterol (VLDL-C), triglyceride (TG), and body mass index (BMI) were the main outcomes. Results. Seven out of 13 relevant studies met the criteria and were included in the meta-analysis. HbA1c change in diabetic patients in Cr supplement therapy comparing to Pl was -0.33 with 95%CI= -0.72 to 0.06 (P= 0.1). Change of FBG in Cr therapy vs. Pl was -0.95 with 95%CI= -1.42 to -0.49 (P< 0.0001). TC change in Cr therapy vs. Pl was 0.07 with 95%CI= -0.16 to 0.31 (P= 0.54). TG change in diabetic patients in Cr supplement therapy comparing to Pl was -0.15 with 95%CI= -0.36 to 0.07 (P= 0.18). Conclusions. Cr lowers FBS but does not affect HbA1c, lipids and BMI. This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For Readers”) may comment by clicking on ABSTRACT on the issue’s contents page.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Chromium Supplementation on Glucose Metabolism and Lipids
Balk, E. M., Tatsioni, A., Lichtenstein, A. H., Lau, J., & Pittas, A. G. (2007) · Diabetes Care · doi:10.2337/dc06-0996 · Cited by 294
Value of Self-Monitoring Blood Glucose Pattern Analysis in Improving Diabetes Outcomes
Parkin, C. G., & Davidson, J. A. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300314 · Cited by 96 · cited 1×
“A significant increase in costs of long-term treatment of diabetes and its complications is felt (2).”
Background
Cited by
Liu, Y., Cotillard, A., Vatier, C., Bastard, J.-P., Fellahi, S., Stévant, M., Allatif, O., Langlois, C., Bieuvelet, S., Brochot, A., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138646 · Cited by 71
“The use of chromium in the treatment of T2D has been debated [39;73;74].”
BackgroundWhitfield, P., Parry-Strong, A., Walsh, E., Weatherall, M., & Krebs, J. D. (2016) · European Journal of Nutrition · doi:10.1007/s00394-015-0926-x · Cited by 51
“The effects of supplementation in patients with T2DM who are not deficient in this micronutrient are less well understood; however, it is proposed that chromium supplementation may lead to improved glycaemic control by stimulating insulin receptors, increasing the activity of glucokinase in the liver and enhancing bet…”
BackgroundResultJamilian, M., & Asemi, Z. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000438465 · Cited by 38
Metadata
- Authors
- Abdollahi, M., Farshchi, A., Nikfar, S., & Seyedifar, M.
- Venue
- Journal of Pharmacy & Pharmaceutical Sciences
- Publisher
- Frontiers Media SA
- Published
- 2013-04-30
- Volume
- 16
- Issue
- 1
- Pages
- 99
- ISSN
- 1482-1826 (ISSN-L)
- OpenAlex
- W1540087018
- Cited by
- 67
- References
- 2
- FWCI
- 1.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.